Stocks and Investing Stocks and Investing
Wed, December 18, 2019
Tue, December 17, 2019

David Lewis Maintained (ABT) at Buy with Increased Target to $101 on, Dec 17th, 2019


Published on 2024-10-26 19:15:48 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $93 to $101 on, Dec 17th, 2019.

David has made no other calls on ABT in the last 4 months.



There are 2 other peers that have a rating on ABT. Out of the 2 peers that are also analyzing ABT, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $98 on, Thursday, October 17th, 2019
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $90 on, Monday, October 14th, 2019

Contributing Sources